Bruce Neal's Publications

Yin X, Paige E, Tian M et alii
The Proportion of Dietary Salt Replaced With Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up.
Journal articles
2023
Hypertension
Trieu K, Coyle DH, Rosewarne E et alii
Estimated Dietary and Health Impact of the World Health Organization's Global Sodium Benchmarks on Packaged Foods in Australia: a Modeling Study.
Journal articles
2023
Hypertension
Sanuade OA, Alfa V, Yin X et alii
Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-up
Journal articles
2023
PLoS ONE
Ojo AE, Jones A, Okoro CE et alii
Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study
Journal articles
2023
Nutrients
Carcel C, Neal B, Rogers K et alii
S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL
Journal articles
2023
Journal of Hypertension
Marklund M, Cherukupalli R, Pathak P et alii
Hypertension treatment capacity in India by increased workforce, greater task-sharing, and extended prescription period: A modelling study
Journal articles
2023
The Lancet Regional Health - Southeast Asia
Coyle DH, Huang L, Shahid M et alii
Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel
Journal articles
2022
International Journal of Behavioral Nutrition and Physical Activity
Rasmussen DGK, Hansen MK, Blair J et alii
Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial
Journal articles
2022
Cardiovascular Diabetology
Tye SC, Jongs N, Coca SG et alii
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
Journal articles
2022
Cardiovascular Diabetology
Crosby S, Rajadurai E, Jan S et alii
The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review
Journal articles
2022
Humanities and Social Sciences Communications
Baigent C, Emberson JR, Haynes R et alii
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
Journal articles
2022
The Lancet
Sarraju A, Bakris G, Cannon CP et alii
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria
Journal articles
2022
Journal of the American College of Cardiology
Koshino A, Schechter M, Sen T et alii
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
Journal articles
2022
Diabetes Care
Wu JHY, Trieu K, Coyle D et alii
Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia
Journal articles
2022
Journal of Nutrition
Eyles H, Grey J, Jiang Y et alii
A sodium reduction smartphone app and reduced sodium salt for adults with hypertension: Findings from the SALTS randomized controlled trial (Preprint)
Preprints
2022
http://dx.doi.org/10.2196/preprints.43675
Neuen B, Fletcher R, Arnott C et alii
CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL
Conference Abstracts
2022
in NEPHROLOGY
Arnott C, Fletcher RA, Neal B
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
Journal articles
2022
Heart Failure Clinics
Yin X, Rodgers A, Perkovic A et alii
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis
Journal articles
2022
Heart
Marklund M, Tullu F, Thout SR et alii
Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study
Journal articles
2022
Hypertension
Maganja D, Trieu K, Reading M et alii
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial
Journal articles
2022
American Heart Journal
Sen T, Koshino A, Neal B et alii
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial
Journal articles
2022
Diabetes
Li C, Yu J, Hockham C et alii
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis
Journal articles
2022
Diabetes
Nadkarni GN, Takale D, Neal B et alii
A Post Hoc Analysis of KidneylntelX and Cardiorenal Outcomes in Diabetic Kidney Disease
Journal articles
2022
KIDNEY360
Liu Y, Xiao S, Yin X et alii
Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review
Journal articles
2022
Public Health Reviews
Tye S, Jong N, Coca SG et alii
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney outcome guided by HbA(1c) and predicted risk of kidney failure
Conference Papers
2022
in DIABETOLOGIA
Schechter M, Koshino A, Jongs N et alii
Novel subgroups of patients with type 2 diabetes show differential cardiovascular and kidney benefits with canagliflozin: a data-driven proteomic cluster analysis
Conference Papers
2022
in DIABETOLOGIA

Bruce Neal's Publications

The Proportion of Dietary Salt Replaced With Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up.

Estimated Dietary and Health Impact of the World Health Organization's Global Sodium Benchmarks on Packaged Foods in Australia: a Modeling Study.

Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-up

Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study

S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL

Hypertension treatment capacity in India by increased workforce, greater task-sharing, and extended prescription period: A modelling study

Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel

Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia

A sodium reduction smartphone app and reduced sodium salt for adults with hypertension: Findings from the SALTS randomized controlled trial (Preprint)

CANAGLIFLOZIN AND DIURETIC USE IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE CREDENCE TRIAL

Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis

Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study

Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial

Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis

A Post Hoc Analysis of KidneylntelX and Cardiorenal Outcomes in Diabetic Kidney Disease

Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney outcome guided by HbA(1c) and predicted risk of kidney failure

Novel subgroups of patients with type 2 diabetes show differential cardiovascular and kidney benefits with canagliflozin: a data-driven proteomic cluster analysis

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country